Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CCDC144CP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
YTHDC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MEIG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WDR26 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZFAND5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CASD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00339 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
AGBL3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SCN8A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100132356 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CD84 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ERICH3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZBTB3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VWA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MYLIP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PTRH1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on